Innovation & Produktdefinition
The development process ends with the submission to the competent authorities for marketing approval. After approximately one year of evaluation by the authorities, which confirms that the development and the collected data complies with regulations, permission is granted to distribute the drug commercially, which allows doctors to prescribe the new medication for the treatment of patients.
Develco Pharma has an extensive and remarkable expertise in the development of medicinal products. This expertise does include innovative and creative approaches to difficult problems. This advantage in knowledge results in development and approval of new products within a shortened timeframe.
In-house, the focus lies in the technical development comprising of formulation and analytical development as well as production scale-up. Preclinical and clinical development, as well as in the regulatory approval process, Develco Pharma can look back on a long and successful cooperation with designated experts and specialized companies. However, Develco Pharma is capable to control the entire development process with its own employees and infrastructure.